Notice of General Meeting

Summary by AI BETAClose X

CRISM Therapeutics Corporation has announced a General Meeting to be held on Monday, June 15, 2026, at 10:00 a.m. This meeting follows the Company's Fundraising announcement on May 26, 2026, and further details will be posted to shareholders. The company is a UK clinical-stage drug delivery firm focused on localized and sustained chemotherapy delivery for solid tumors, with its lead product, ChemoSeed, designed for direct implantation into tumors or resection margins.

Disclaimer*

UK 100

Latest directors dealings